The guardian of the genome, TP53 tumor suppressor gene was found mutated in 85% of colorectal cancers [290] with 70% of the TP53 mutations were linked to adenoma-to-carcinoma progression, an aggressive subset of CRC [291,292]. This evidence concerns the gene TP53 and adenoma.